))
AI Drug DIscovery with Rick Fine, Founder and CEO at Phronesis AI
Manage episode 409831886 series 3565535
Content provided by Alec Crawford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alec Crawford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In the AI Risk Reward podcast, our host, Alec Crawford, Founder and CEO of Artificial Intelligence Risk, Inc. (https://www.aicrisk.com), interviews guests about Artificial Intelligence. They discuss how to use AI effectively to generate value and the different risks AI creates, as well as how to mitigate risks with governance, risk, compliance, and cybersecurity (GRCC).
Podcast production and sound engineering by Troutman Street Audio. You can find them on LinkedIn and at https://www.troutmanstreetaudio.com.
In this episode, Alec interviews Rick Fine, Co-Founder and CEO of Phronesis AI. Rick discusses his background in building companies and the lessons he has learned along the way. He shares his love for independence and adventure, going back to his experiences as a latchkey kid. Rick also talks about Sleeping Donkey, a company he co-founded for partnering in business growth.
The conversation then transitions to drug discovery and the use of AI in the process. Rick emphasizes the genius and character of his partner, Will Spagnoli, and explains the concept of de novo molecules. He discusses the strategy for Phronesis Artificial Intelligence, focusing on partnerships and licensing. Rick shares the partnership with Temple University and the potential value of their output. He also discusses the ethical considerations of AI and expresses optimism for the future.
Key Takeaways
- Building companies requires perseverance and a willingness to take action and risk.
- Independence and adventure can shape one's entrepreneurial journey.
- AI plays a crucial role in drug discovery, enabling the design of de novo molecules.
- Partnerships and licensing can accelerate the development and commercialization of drugs.
- Ethical considerations and responsible use of AI are important in the industry.
- Optimism for the future lies in meeting basic needs, promoting peace, and advancing healthcare.
Resources
https://www.phronesisai.com/
https://www.linkedin.com/company/phronesis-ai/
Books Mentioned
Huckleberry Finn by Mark Twain
11 episodes
Share
